An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis

By sjmartinez • June 20, 2024

Shah A, Tabibian J, Buness C, Holtmann GJ. An 'Adaptive Treatment Strategy' for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis. Dig Dis Sci. 2024 Jun 19. doi: 10.1007/s10620-024-08497-4. Epub ahead of print. PMID: 38896361.

Tags: Adaptive treatment strategy, Digestive Diseases, Olive View DoM, Oral vancomycin, Orphan disease, Primary sclerosing cholangitis, Publications, rare disease, Therapeutic decision-making

The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]

The management of hepatorenal syndrome-acute kidney injury (HRS-AKI): A national survey of hepatology provider practices

Cullaro G, Im GY, Chandna S, Lee BT, Simonetto DA, Aby ES, Izzy M, Gonzalez SA, Sherman CB, Aron J, Luther J, Goel A, Jophlin[...]

Disparities in Healthcare Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results from a US Survey

Almario CV, Liu J, Higgins C, Yerneni N, Boules M, Chey WD, Chang L. Disparities in Healthcare Seeking and Physician Diagnosis of Irritable Bowel Syndrome:[...]